Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 USD | -0.34% | -5.65% | -7.75% |
May. 30 | Transcript : Roivant Sciences Ltd., Q4 2024 Earnings Call, May 30, 2024 | |
May. 30 | Roivant Sciences' Fiscal Q4 Net Loss Widens, Revenue Rises | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.75% | 7.65B | |
+40.73% | 739B | |
+31.59% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.62% | 240B | |
+9.46% | 210B | |
-4.91% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Transcript : Roivant Sciences Ltd. Presents at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ, May-20-2024 09